Efstathios Kastritis is Associate Professor of Clinical Therapeutics/Medical Oncology at the Department of Clinical Therapeutics at the National and Kapodistrian University of Athens, School of Medicine. He graduated from the National and Kapodistrian University of Athens School of Medicine and completed his residency in Internal Medicine and fellowship in Medical Oncology at the Department of Clinical Therapeutics. He received his Doctorate from the National and Kapodistrian University of Athens and was a post-doctoral Fellow at the Jerome Lipper Multiple Myeloma Center, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute. His research interests include plasma cell dyscrasias, especially multiple myeloma, Waldenström’s macroglobulinemia and amyloidosis. He has authored or co-authored more than 195 papers published in peer reviewed journals with a main focus on the treatment of plasma cell dyscrasias, identification of prognostic factors and management of disease complications, and he is also participating in many phase 2 and 3 clinical trials as a Principal Investigator or Sub-Investigator in multiple myeloma, amyloidosis and Waldenström’s macroglobulinemia.
You can see my upcoming and previous webinars here.
